Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Pettengell

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2014
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic reviewAlena M Pfeil, Kim Allcott, Ruth Pettengell, et al.
British Journal of Haematology|April 13, 2011
Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)Claire E Dearden, Rod Johnson, Ruth Pettengell, et al.
European Journal of Haematology|December 12, 2003
Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrowColin P McGuckin, Daniel Pearce, Nicolas Forraz, et al.
Clinical Chemistry|August 22, 2009
Measurement of ribosomal RNA turnover in vivo by use of deuterium-labeled glucoseJulien Defoiche, Yan Zhang, Laurence Lagneaux, et al.
Clinical Drug Investigation|July 14, 2009
Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma careRuth Pettengell, Matti Aapro, Ercole Brusamolino, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2008
Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia studyRuth Pettengell, Matthias Schwenkglenks, Robert Leonard, et al.
British Journal of Haematology|December 6, 2008
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia StudyRuth Pettengell, André Bosly, Thomas D Szucs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2010
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia StudyMatthias Schwenkglenks, Ruth Pettengell, Christian Jackisch, et al.
Clinical Therapeutics|February 10, 2016
The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin's LymphomaNoemi Muszbek, Ananth Kadambi, Tereza Lanitis, et al.
Stem Cells (Dayton, Ohio)|March 14, 2003
Colocalization analysis of sialomucins CD34 and CD164Colin P McGuckin, Nicolas Forraz, Marc-Olivier Baradez, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2014
Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic reviewAlena M Pfeil, Kim Allcott, Ruth Pettengell, et al.
British Journal of Haematology|April 13, 2011
Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)Claire E Dearden, Rod Johnson, Ruth Pettengell, et al.
European Journal of Haematology|December 12, 2003
Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrowColin P McGuckin, Daniel Pearce, Nicolas Forraz, et al.
Clinical Chemistry|August 22, 2009
Measurement of ribosomal RNA turnover in vivo by use of deuterium-labeled glucoseJulien Defoiche, Yan Zhang, Laurence Lagneaux, et al.
Clinical Drug Investigation|July 14, 2009
Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma careRuth Pettengell, Matti Aapro, Ercole Brusamolino, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2008
Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia studyRuth Pettengell, Matthias Schwenkglenks, Robert Leonard, et al.
British Journal of Haematology|December 6, 2008
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia StudyRuth Pettengell, André Bosly, Thomas D Szucs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2010
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia StudyMatthias Schwenkglenks, Ruth Pettengell, Christian Jackisch, et al.
Clinical Therapeutics|February 10, 2016
The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin's LymphomaNoemi Muszbek, Ananth Kadambi, Tereza Lanitis, et al.
Stem Cells (Dayton, Ohio)|March 14, 2003
Colocalization analysis of sialomucins CD34 and CD164Colin P McGuckin, Nicolas Forraz, Marc-Olivier Baradez, et al.
Pageof 8